DIBENZOXEPIN DERIVATIVES - THROMBOXANE-A(2) SYNTHASE INHIBITION AND THROMBOXANE A(2)-RECEPTOR ANTAGONISM COMBINED IN ONE MOLECULE

被引：11

作者：

OHSHIMA, E

SATO, H

OBASE, H

MIKI, I

ISHII, A

KAWAKAGE, M

SHIRAKURA, S

KARASAWA, A

KUBO, K

机构：

[1] Pharmaceutical Research Laboratories, Kyowa Hakko Kogyo Co., Ltd., Shizuoka, 411, 1188 Shimotogari, Nagaizumi-cho, Sunto-gun

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 1993年 / 36卷 / 11期

关键词：

D O I：

10.1021/jm00063a011

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A new series of 6,11-dihydrodibenz[b,e]oxepin derivatives exerting both thromboxane synthase inhibitory (TXS-I) and thromboxane receptor antagonist (TXRA) activities is described. (-)-ll-[(3-Pyridylmethyl)thio]-6,11-dihydrodibenz[b,e]oxepin-2-carboxylic acid [(-)-3] and (E)-11-[2-(3-pyridyl)ethylidene]-6,11-dihydrodibenz[b,e]oxepin-2-carboxylic acid methanesulfonate (11E) exhibited potent inhibitory effects on bovine platelet thromboxane synthase with IC50 values of 4.0 and 14 nM, respectively, and these derivatives also antagonized guinea pig platelet TXA2/PGH2 receptors with K(i) values of 85 and 180 nM, respectively. Compound 11E exhibited the dual inhibitory activity in ex vivo experiments and demonstrated a significant protective effect in a rat acute renal failure model.

引用

页码：1613 / 1618

页数：6

共 50 条

[1] ROLE OF PROAGGREGATORY AND ANTIAGGREGATORY PROSTAGLANDINS IN HEMOSTASIS - STUDIES WITH COMBINED THROMBOXANE SYNTHASE INHIBITION AND THROMBOXANE RECEPTOR ANTAGONISM
GRESELE, P
ARNOUT, J
DECKMYN, H
HUYBRECHTS, E
PIETERS, G
VERMYLEN, J
JOURNAL OF CLINICAL INVESTIGATION, 1987, 80 (05): : 1435 - 1445
[2] G-619 - A NOVEL DUAL THROMBOXANE SYNTHASE INHIBITOR AND THROMBOXANE-A(2) RECEPTOR ANTAGONIST
SQUADRITO, F
ALTAVILLA, D
SPIGNOLI, G
CANALE, P
IOCULANO, M
CAMPO, GM
CAPUTI, AP
CARDIOVASCULAR DRUG REVIEWS, 1993, 11 (01): : 116 - 125
[3] Cyclooxygenases, thromboxane, and atherosclerosis -: Plaque destabilization by cyclooxygenase-2 inhibition combined with thromboxane receptor antagonism
Egan, KM
Wang, M
Lucitt, MB
Zukas, AM
Puré, E
Lawson, JA
FitzGerald, GA
CIRCULATION, 2005, 111 (03) : 334 - 342
[4] THROMBOXANE-A2 RECEPTOR ANTAGONISM AND SYNTHASE INHIBITION IN ESSENTIAL-HYPERTENSION
RITTER, JM
BARROW, SE
DOKTOR, HS
STRATTON, PD
EDWARDS, JS
HENRY, JA
GOULD, S
HYPERTENSION, 1993, 22 (02) : 197 - 203
[5] THROMBOXANE SYNTHASE INHIBITION AND THROMBOXANE-A2 ENDOPEROXIDE RECEPTOR ANTAGONISM IN A CANINE MODEL OF CORONARY-THROMBOSIS
FITZGERALD, D
FRAGETTA, J
FITZGERALD, GA
CIRCULATION, 1985, 72 (04) : 422 - 422
[6] THROMBOXANE RECEPTOR ANTAGONISM COMBINED WITH THROMBOXANE SYNTHASE INHIBITION .1. (+/-)-(3-PYRIDINYLBICYCLOHEPTYL)ALKANOIC ACIDS
BHAGWAT, SS
GUDE, C
COHEN, DS
LEE, W
FURNESS, P
CLARKE, FH
JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (06) : 1790 - 1797
[7] Terbogrel, a dual-acting agent for thromboxane receptor antagonism and thromboxane synthase inhibition
Michaux, C
Norberg, B
Dogné, JM
Durant, F
Masereel, B
Delarge, J
Wouters, J
ACTA CRYSTALLOGRAPHICA SECTION C-CRYSTAL STRUCTURE COMMUNICATIONS, 2000, 56 (56) : 1265 - 1266
[8] EFFECTS OF COMBINED THROMBOXANE SYNTHETASE INHIBITION THROMBOXANE RECEPTOR ANTAGONISM IN 2 MODELS OF SUDDEN CARDIAC DEATH IN THE CANINE - LIMITED ROLE FOR THROMBOXANE
KITZEN, JM
CHI, LG
UPRICHARD, ACG
LUCCHESI, BR
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1990, 16 (01) : 68 - 80
[9] THROMBOXANE RECEPTOR ANTAGONISM COMBINED WITH THROMBOXANE SYNTHASE INHIBITION .7. PYRIDINYLALKYL-SUBSTITUTED ARYLSULFONYLAMINO ARYLALKANOIC ACIDS
BHAGWAT, SS
ROLAND, DM
MAIN, AJ
GUDE, C
GRIM, K
GOLDSTEIN, R
COHEN, DS
DOTSON, R
MATHIS, J
LEE, W
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1992, 2 (12) : 1623 - 1626
[10] New tetrahydronaphthalene derivatives as combined thromboxane receptor antagonists and thromboxane synthase inhibitors
Cimetière, B
Dubuffet, T
Landras, C
Descombes, JJ
Simonet, S
Verbeuren, TJ
Lavielle, G
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (11) : 1381 - 1386

← 1 2 3 4 5 →